Vise Technologies Inc. Purchases 1,892 Shares of HCA Healthcare, Inc. $HCA

Vise Technologies Inc. grew its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 17.0% in the fourth quarter, Holdings Channel reports. The fund owned 12,998 shares of the company’s stock after acquiring an additional 1,892 shares during the quarter. Vise Technologies Inc.’s holdings in HCA Healthcare were worth $6,068,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of HCA. Brighton Jones LLC bought a new position in HCA Healthcare during the 4th quarter worth $1,021,000. NewEdge Advisors LLC raised its position in HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC raised its position in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC bought a new position in HCA Healthcare during the 2nd quarter worth $2,073,000. Finally, Sei Investments Co. raised its position in HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after purchasing an additional 49,214 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on HCA shares. Deutsche Bank Aktiengesellschaft lowered their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research report on Tuesday, April 28th. TD Cowen lowered their price objective on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, April 27th. Robert W. Baird lowered their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Sanford C. Bernstein lowered their price objective on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a research report on Thursday. Finally, Mizuho lifted their price objective on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $506.14.

Read Our Latest Analysis on HCA

HCA Healthcare Price Performance

Shares of HCA opened at $372.29 on Friday. The stock has a 50-day moving average of $439.51 and a 200-day moving average of $477.20. The company has a market cap of $82.59 billion, a PE ratio of 12.80, a P/E/G ratio of 1.15 and a beta of 1.12. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.